Evidence map›Paper›PMID 28123863›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2017

Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer.

Fabio D Almeida, Chi-Kwan Yen, Mark C Scholz, Richard Y Lam, Jeffrey Turner, Larry L Bans, Robert Lipson

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Head to head comparison performance ofAmerican journal of nuclear medicine and molecular imaging · 2018
    Article
  6. Article
  7. Positron emission tomography in prostate cancer: An update on state of the art.Indian journal of urology : IJU : journal of the Urological Society of India
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Fabio D AlmeidaPhoenix Molecular Imaging Phoenix, AZ, USA.
Chi-Kwan YenPhoenix Molecular Imaging Phoenix, AZ, USA.
Mark C ScholzProstate Oncology Specialists Marina Del Rey, CA, USA.
Richard Y LamProstate Oncology Specialists Marina Del Rey, CA, USA.
Jeffrey TurnerProstate Oncology Specialists Marina Del Rey, CA, USA.
Larry L Bans21st Century Oncology Scottsdale, AZ, USA.
Robert Lipson21st Century Oncology Scottsdale, AZ, USA.
Marina Del Rey Hospital · US21st Century Oncology (United States) · USPhoenix Molecular Imaging · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An elevated serum prostate-specific antigen (PSA) level alone cannot distinguish between local-regional recurrences and distant metastases after treatment with curative intent. With available salvage treatments, it has become important to localize the site of recurrence.

Indexed as

carbon-11 acetatepositron emission tomographyProstate cancerPSA recurrence

Identifiers

PMID28123863
PMCPMC5259584
OpenAlexW2584963702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.